Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Amino Acids and Derivatives
    (1)
  • Endogenous Metabolite
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Metabolism
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

l m tyrosine

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    2
    TargetMol | Natural_Products
L-m-Tyrosine
LmTyrosine, L(-)mTyrosine, L-(-)-m-Tyrosine, L (-) m Tyrosine, 3-Hydroxy-L-Phenylalanine
T19922587-33-7
L-m-Tyrosine (3-Hydroxy-L-Phenylalanine) is a non-natural amino acid. L-(-)-m-Tyrosine displays the potential in treating Parkinson's disease, arthritis, and Alzheimer's disease.
  • $38
In Stock
Size
QTY
DL-m-Tyrosine
T13654775-06-4
DL-m-Tyrosine is a non-proteinogenic amino acid. It inhibits microbial proliferation and spore formation, and significantly suppresses root development of lettuce, Arabidopsis thaliana and other plants. Combined with carbidopa, it exerts significant antihypertensive pharmacological activity and can be used as a research tool in the development and mechanism exploration of biopesticides.
  • $33
In Stock
Size
QTY
H-Tyr(3-I)-OH
3-Iodo-L-tyrosine
T556870-78-0
H-Tyr(3-I)-OH (3-Iodo-L-tyrosine) is an inhibitor of tyrosine hydroxylase (Ki = 0.39 M) and an intermediate in the synthesis of thyroid hormones
  • $29
Inquiry
Size
QTY
DW532
T710821267949-42-7
DW532 is one of simplified analogues of hematoxylin that has shown broad-spectrum inhibition on tyrosine kinases and in vitro anti-cancer activities. DW532 inhibited EGFR and VEGFR2 in vitro kinase activity (the IC50 values were 4.9 and 5.5 μmol/L, respectively), and suppressed their downstream signaling. DW532 dose-dependently inhibited tubulin polymerization via direct binding to tubulin, thus disrupting the mitotic spindle assembly and leading to abnormal cell division. In a panel of human cancer cells, DW532 (1 and 10 μmol/L) induced G2/M phase arrest and cell apoptosis, which subsequently resulted in cytotoxicity. Knockdown of BubR1 or Mps1, the two core proteins of the spindle assembly checkpoint dramatically decreased DW532-induced cell cycle arrest in MDA-MB-468 cells. Moreover, treatment with DW532 potently and dose-dependently suppressed angiogenesis in vitro and in vivo. ( Acta Pharmacol Sin. 2014 Jul;35(7):916-28.)
  • $1,520
6-8 weeks
Size
QTY